PT92187A - Processo para a preparacao de neoglicoproteinas e de agentes de diagnostico que as contem - Google Patents

Processo para a preparacao de neoglicoproteinas e de agentes de diagnostico que as contem

Info

Publication number
PT92187A
PT92187A PT92187A PT9218789A PT92187A PT 92187 A PT92187 A PT 92187A PT 92187 A PT92187 A PT 92187A PT 9218789 A PT9218789 A PT 9218789A PT 92187 A PT92187 A PT 92187A
Authority
PT
Portugal
Prior art keywords
neoglyoproteins
preparation
diagnostic agents
neoglycoproteins
monosialolactose
Prior art date
Application number
PT92187A
Other languages
English (en)
Other versions
PT92187B (pt
Inventor
Klaus Bosslet
Hans Harald Sedlacek
Herbert Wiegand
Silke Bosslet
Original Assignee
Behringwerke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke Ag filed Critical Behringwerke Ag
Publication of PT92187A publication Critical patent/PT92187A/pt
Publication of PT92187B publication Critical patent/PT92187B/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/385Haptens or antigens, bound to carriers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/0005Vertebrate antigens
    • A61K39/0011Cancer antigens
    • A61K39/001169Tumor associated carbohydrates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531Production of immunochemical test materials
    • G01N33/532Production of labelled immunochemicals
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/60Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031Proteins
    • A61K2039/6081Albumin; Keyhole limpet haemocyanin [KLH]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PT92187A 1988-11-05 1989-11-03 Processo para a preparacao de neoglicoproteinas e de agentes de diagnostico que as contem PT92187B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3837623A DE3837623A1 (de) 1988-11-05 1988-11-05 Neoglykoproteine, ihre herstellung und verwendung

Publications (2)

Publication Number Publication Date
PT92187A true PT92187A (pt) 1990-05-31
PT92187B PT92187B (pt) 1995-06-30

Family

ID=6366580

Family Applications (1)

Application Number Title Priority Date Filing Date
PT92187A PT92187B (pt) 1988-11-05 1989-11-03 Processo para a preparacao de neoglicoproteinas e de agentes de diagnostico que as contem

Country Status (12)

Country Link
EP (1) EP0368131B1 (pt)
JP (1) JP2838147B2 (pt)
KR (1) KR0162635B1 (pt)
AT (1) ATE142229T1 (pt)
AU (1) AU630634B2 (pt)
CA (1) CA2002218C (pt)
DE (2) DE3837623A1 (pt)
DK (1) DK549589A (pt)
ES (1) ES2093612T3 (pt)
GR (1) GR3021111T3 (pt)
IE (1) IE76312B1 (pt)
PT (1) PT92187B (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3840044A1 (de) * 1988-11-27 1990-06-07 Behringwerke Ag Glykosphingolipide mit kopplungsfaehiger gruppe im sphingoidanteil, ihre herstellung und verwendung
EP0646377A1 (en) * 1993-10-01 1995-04-05 LUANFARMA S.r.l. Albumin-conjugated tumour cell-free extracts, antigenic compositions comprising the same, related antibodies, and uses thereof
US5977316A (en) * 1995-01-17 1999-11-02 The Board Of Trustees Of The University Of Kentucky Monoclonal antibody 1A7 and related polypeptides
US5935821A (en) * 1995-01-17 1999-08-10 Board Of Trustees Of The University Of Kentucky Polynucleotides related to monoclonal antibody 1A7 and use for the treatment of melanoma and small cell carcinoma
US5612030A (en) 1995-01-17 1997-03-18 University Of Kentucky Research Foundation Anti-idiotype monoclonal antibody 1A7 and use for the treatment of melanoma and small cell carcinoma
EP0839053A2 (en) * 1995-07-14 1998-05-06 GlycoTech Corp. Compounds and methods for treatment of egf receptor associated cancers and purification of the egf receptor
US6355244B1 (en) 1997-11-17 2002-03-12 University Of Kentucky Research Foundation Methods and compositions for the treatment of psoriasis

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4557931A (en) * 1982-12-02 1985-12-10 Regents Of The University Of California Antigenic compositions and methods for using same
DE3840044A1 (de) * 1988-11-27 1990-06-07 Behringwerke Ag Glykosphingolipide mit kopplungsfaehiger gruppe im sphingoidanteil, ihre herstellung und verwendung

Also Published As

Publication number Publication date
GR3021111T3 (en) 1996-12-31
ES2093612T3 (es) 1997-01-01
KR900007429A (ko) 1990-06-01
JPH02173000A (ja) 1990-07-04
CA2002218C (en) 2000-08-08
DK549589D0 (da) 1989-11-03
CA2002218A1 (en) 1990-05-05
DE58909720D1 (de) 1996-10-10
DE3837623A1 (de) 1990-05-10
PT92187B (pt) 1995-06-30
IE893548L (en) 1990-05-05
JP2838147B2 (ja) 1998-12-16
KR0162635B1 (ko) 1998-11-16
ATE142229T1 (de) 1996-09-15
EP0368131A3 (en) 1990-12-19
AU4436889A (en) 1990-05-10
DK549589A (da) 1990-05-06
EP0368131B1 (de) 1996-09-04
EP0368131A2 (de) 1990-05-16
AU630634B2 (en) 1992-11-05
IE76312B1 (en) 1997-10-22

Similar Documents

Publication Publication Date Title
ES521418A0 (es) Procedimiento para la preparacion de proteinas funcionales de uroquinasa humana.
FI104255B1 (fi) Menetelmä ihmisen seerumialbumiinin N-terminaalifragmentteja sisältävien fuusioproteiinien valmistamiseksi
DE69329538D1 (de) Chlorophyll- und Bakteriochlorophyll-Derivate, ihre Herstellung und diese enthaltende pharmazeutische Zubereitungen
ZA873299B (en) Formulations containing unsaturated fatty acids for the synthesis of prostablandins and hydroxy-fatty acids in biological systems
ES2137935T3 (es) Preparaciones farmaceuticas que contienen una anticitoquina.
NO874740L (no) Syntetisk antigen for paavisning av aids-relaterte sykdommer.
GB8824869D0 (en) Synthetic antibody
PT92187A (pt) Processo para a preparacao de neoglicoproteinas e de agentes de diagnostico que as contem
KR890700662A (ko) 바이러스 항원과 그의 제조방법 및 진단과 치료를 목적으로 하는 사용방법
IT8483359A0 (it) Procedimento per ottenere lapreparazione di concentrati e nutrimenti proteici dal sangue animale.
SE8404283L (sv) Anvendning av ett specifikt tumorassocierat antigen, nemligen sialosyllaktotetraos, for diagnostiska och terapeutiska forfaranden vid cancersjukdomar
FI101597B1 (fi) Menetelmä kylmäkuivatun koostumuksen valmistamiseksi käytettäväksi potilaan valodynaamisessa hoidossa tai diagnosoinnissa
ZA833483B (en) In vitro diagnostic methods using monoclonal antibodies against connective tissue proteins
PT81093B (pt) Processo para a preparacao de uma composicao terapeutica para tratamento de um tumor
ATE160359T1 (de) Antigene regionen von tumorfreigestzten partikeln (tlp) komplexen und antikörper die sie erkennen.
ES2074983T3 (es) Procedimieto para el aislamiento de proteinas de membranas basales a partir de tejidos humanos y animales.
FI884470A (fi) Biologiskt diagnostiskt analyseringssystem.
ZA875676B (en) The use of 15-deoxyspergualine as a pharmaceutical
PT89224A (pt) Processo para a preparacao de peptidos para o bloqueamento da actividade do pai-1 no sangue humano e sua utilizacao na preparacao de anticorpos
ATE95422T1 (de) Ein synthetisches nonapeptid zur verwendung als adjuvant.
GB8728453D0 (en) Agents for removing human immunodeficiency virus & related compounds
FR2618439B1 (fr) Sequences d'amino-acides reproduisant au moins en partie la sequence des lectines animales et humaines, leurs procedes d'obtention, leurs applications diagnostiques et therapeutiques
IT1192016B (it) Procedimento perfezionato per la confezione di libri composti di segnature cucite
DE3784364D1 (de) Tumorassoziiertes antigen.
SU1077090A1 (ru) Способ получени вещества,специфически св зывающего раково-эмбриональный антиген опухолей толстого кишечника человека

Legal Events

Date Code Title Description
MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20020630